Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNH2 | Q12809 | 2/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.34 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.32 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.32 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.32 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.32 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15853289 | 1.00 | KCNH2 (0.39) | KCNH2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL15853287 | 1.00 | KCNH2 (0.39) | KCNH2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL17509621 | 0.75 | KCNH2 (0.49) | KCNH2MAPTNPC1RAB9ACYP3A4 | |
| SCHEMBL15853291 | 0.75 | MAPT (0.45) | MAPTCYP3A4TSHR | |
| SCHEMBL15780508 | 0.73 | MAPT (0.31) | MAPT | |
| SCHEMBL15853281 | 0.73 | MAPT (0.34) | MAPT | |
| SCHEMBL7912520 | 0.71 | KCNH2 (0.42) | KCNH2NPC1RAB9AMEN1KMT2A | |
| SCHEMBL20917299 | 0.70 | MEN1 (0.39) | KCNH2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL718529 | 0.70 | KCNH2 (0.46) | KCNH2MAPTNPC1RAB9AMEN1 | |
| SCHEMBL719932 | 0.70 | KCNH2 (0.46) | KCNH2MAPTNPC1RAB9AMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150236269-A1 | ORGANIC SEMICONDUCTOR SOLUTION AND ORGANIC SEMICONDUCTOR FILM | TEIJIN LIMITED (JP) | 2015-08-20 | — | — | US | disclosed |
| US-8829202-B2 | Condensed polycyclic aromatic compound, aromatic polymer, and method for synthesizing aromatic compound | TEIJIN LIMITED (JP) | 2014-09-09 | — | — | US | disclosed |
| US-20140187792-A1 | CONDENSED POLYCYCLIC AROMATIC COMPOUND, AROMATIC POLYMER, AND METHOD FOR SYNTHESIZING AROMATIC COMPOUND | TEIJIN LIMITED (JP) | 2014-07-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140187792-A1 | CONDENSED POLYCYCLIC AROMATIC COMPOUND, AROMATIC POLYMER, AND METHOD FOR SYNTHESIZING AROMATIC COMPOUND | PAH, C9, CCNB2 | KCNH2 343/4885MAPT 3228/4885NPC1 1687/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.